Brand name :EVESYNC SYRUP
Ayurvedic Uterine Tonic
Ayurvedic Uterine Tonic-EVESYNC SYRUP is manufactured from natural materials and is suitable for women. Its numerous natural elements aid in the treatment of women’s issues. Shatavari is beneficial for leukorrhea and hormonal balance. Ashoka helps to regulate the menstrual cycle and improves uterine health. Apamarg controls menorrhagia and relieves discomfort and edoema associated with menstruation. Mineral-rich foods like khajur, amla, nagarmotha, ginger, and kaki nourish both the body and the hair. The tonic as a whole also aids in the treatment of female sexual debility by improving libido.
The medication’s formulation provides comfort to the woman by treating gynecological illnesses such as premenstrual and postmenstrual syndrome. The medicine aids in the regulation of female hormones. This medicine can help a lady who has excessive bleeding during her periods. Following the administration of this medicine, the woman experiences normal and consistent menstruation. The medicine also relieves cramping and mood changes that the woman experiences throughout her periods.
The following measures must be performed in order for the syrup to be effective:
Because the drug is available in syrup form, the person is encouraged to take the exact amount of syrup prescribed by the doctor. It is recommended to make the syrup twice a day or as directed by the doctor.
There are some women who may suffer from the side effects which are as follows :
Biosync Pharma is India’s most well-known pharmaceutical company, offering a wide selection of high-quality medications. The company’s products are of the highest quality since the raw materials used in the creation of our formulas are 100% pure and safe. Our manufacturing and storage facilities are both large and spotless. We sterilize our units on a regular basis and ensure that the environment is dust and contamination-free. Across the country, we offer monopolistic franchise and third-party manufacturing services.
There are no reviews yet.